Collective Tirzepatide Review: $69/Month Plus a Required $199 Membership (2026)

Collective prices the compounded tirzepatide itself at $69 a month, the same figure at every dose, and a $199 annual membership is required before you can buy it at all. Both numbers are published on the homepage, read live on 1 September 2026, but only the medication price reaches the headline, which quotes $59 a month.¹

What the $69 buys, and what the $199 buys

The two charges cover different things, and the split is clear once you find it. The $69 is the medication alone; the membership carries the prescribing, unlimited doctor messaging, check-ins and dose adjustments, nutrition support and two-day cold shipping. There is no dose ladder and no prepay tier, and the flat rate is stated four separate ways. The membership opens with a 21-day free trial that converts on its own, authorizing the full annual charge in advance.

The headline the membership is missing from

The H1 reads $59 a month, which is the semaglutide figure rather than the tirzepatide one, and the required membership is nowhere beside it. It appears further down, in a panel on the product card, in small print beneath the cards and again in the FAQ. A reader who stops at the hero has understated a first year by $199 and picked the wrong molecule's price.

A fee the Terms reserve and never price

Section 5 of the Terms reserves a nominal, uniform technology transaction fee for each electronic prescription, described as covering payment processing rather than the prescribing itself. No amount is given on any page. That sits directly against the marketing promise of no hidden costs, and against the FAQ line that there is one annual membership, one medication price and nothing bolted on top.

The brand-vs-compounded question

Collective sells two compounded injectables and no brand product. It never names a pharmacy, describing them only as independent, third-party licensed United States pharmacies, and the strings 503A and 503B appear nowhere on the site, so the compounding class is not stated either. Compounded product is prepared by a pharmacy, carries no FDA approval of its own, and is not what the trials evaluated — see our guide to whether compounded tirzepatide is still legal in 2026.

How the care model holds up

Collective names its operating entity, a Houston address and a phone number, and the intake's own state selector covers 50 states and the District of Columbia. The product cards say you can cancel anytime. The Terms say cancellation only stops the next renewal, that all membership fees are non-refundable and that partial-period refunds are not provided, so leaving in month two of a paid year forfeits the year. The site also never says whether a medication month is a calendar month or a four-week cycle, and a census found no cadence language at all.

Does the drug work? (Separate from the provider)

The seller question and the drug question are separate, and tirzepatide answers its own well. The trial record runs to about 15% to 21% of body weight over 72 weeks in SURMOUNT-1², and to a win over semaglutide in the SURMOUNT-5 comparison³, all of it on the branded drug at approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

The $69 is a genuinely low medication price and the flat-at-any-dose promise is stated plainly enough to hold the company to. What it is not is the whole bill, and the two places the model gets uncomfortable are a headline that omits a mandatory fee and a Terms section that reserves an unpriced one. Goldspan Health charges $299 on a 28-day cycle and at least states the pharmacy class Collective leaves out, while Longevixx charges $299 a month and names nobody at all, which makes Collective's published address and phone number look like real disclosure. The ranked best tirzepatide providers list sets all three against the field.